Interstitial cystitis: a phenotype and rare variant exome sequencing study

This publication was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,400,000 with 60 percent funding from the CDC/HHS (U01DP006634-01). The contents are those of the author(s) and do not necessarily represent the official views of, nor are they endorsed by, the CDC/HHS or the U.S. Government (CAB). National Institutes of Health grant 1K08HG012374 (JEM). New York-Presbyterian Samberg Scholar (JEM). Thrasher Early Career Research Award (JEM). NIH/NIDDK CAIRIBU Interactions Core U24-DK-127726 (CAB). NICHD Boston Children's Hospital Intellectual and Developmental Disabilities Research Center Molecular Genetics Core Facility U54HD090255. NIDDK George M. O'Brien Urology Cooperative Research Centers Program U54DK104309 (AGG). The eMERGE Network was initiated and funded by NHGRI through the following grants: Phase III: U01HG8657 (Group Health Cooperative/University of Washington); U01HG8685 (Brigham and Women's Hospital); U01HG8672 (Vanderbilt University Medical Center); U01HG8666 (Cincinnati Children's Hospital Medical Center); U01HG6379 (Mayo Clinic); U01HG8679 (Geisinger Clinic); U01HG8680 (Columbia University Health Sciences); U01HG8684 (Children's Hospital of Philadelphia); U01HG8673 (Northwestern University); U01HG8701 (Vanderbilt University Medical Center serving as the Coordinating Center); U01HG8676 (Partners Healthcare/Broad Institute); and U01HG8664 (Baylor College of Medicine).